Acute Myelocytic Leukemia

Search Trials
Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MF and CMML (HSCT 002)
Status:
Not yet recruiting
Last Changed:
Feb 10, 2022
First Changed:
Feb 10, 2022
Disease(s):
Myelofibrosis
Intervention(s):
Tagraxofusp
Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) </= 60y. After First CR
Status:
Terminated
Last Changed:
Oct 29, 2021
First Changed:
Nov 23, 2010
Disease(s):
Leukemia, Myeloid, Acute
Intervention(s):
Human Stem Cell TransplantationConsolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)
Phase 1 Study of Niclosamide in Pediatric Patients With Relapsed and Refractory AML
Status:
Not yet recruiting
Last Changed:
Feb 9, 2022
First Changed:
Jan 12, 2022
Disease(s):
Acute Myeloid Leukemia (AML)
Intervention(s):
Niclosamide
Post Marketing Surveillance (PMS) Study of Mylotarg
Status:
Not yet recruiting
Last Changed:
Jan 12, 2022
First Changed:
Jan 12, 2022
Disease(s):
Acute Myeloid Leukemia
A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Status:
Not yet recruiting
Last Changed:
Dec 23, 2021
First Changed:
Dec 23, 2021
Disease(s):
Leukemia, Myeloid, Acute
Intervention(s):
CC-95251Azacitidine

Connect. Empower. Inspire.